Market Overview

Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET


DNA Sciences, Inc.
(NASDAQ:APDN), announced today it plans to
release financial results for its fiscal 2018 third quarter ended June
30, 2018 after market close on Monday, August 13, 2018. In conjunction
with the release, the Company has scheduled a conference call at 4:30
p.m. Eastern Time that will also be broadcast live over the Internet.


          Applied DNA's Fiscal 2018 Third Quarter Financial Results Conference


Monday, August 13, 2018, at 4:30 p.m. Eastern Time


Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask
for the Applied DNA call; via webcast.

A telephonic replay of the conference call will be available for one day
and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with
the passcode 10122259. The webcast
will be archived in the Investors
of the company's website.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics, personalized
medicine and therapeutics.

Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion. The proprietary DNA-based "CertainT®" platform can be
used to identify, tag, test, and track products, to help assure
authenticity, origin, traceability, sustainability and quality of

SigNature® DNA describes the core technology ingredient that is at the
heart of a family of uncopiable, security and authentication solutions,
targeting a wide range of industries, including but not limited to,
pharmaceuticals and nutraceuticals, textiles and defense materials and
DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing
powerful track-and-trace. Our products provide a forensic chain of
evidence in large commercial ecosystems.

Visit for
more information. Follow us on Twitter and LinkedIn.
Join our mailing

Forward Looking Statements

The statements made by Applied DNA in this press release may be
"forward-looking" in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe Applied
DNA's future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to our lack of
significant revenues, limited financial resources, limited market
acceptance, history of net losses, market competition, risk of not
obtaining regulatory approval and various other factors detailed from
time to time in Applied DNA's SEC reports and filings, including our
Annual Report on Form 10-K filed on December 28, 2017 and our subsequent
quarterly report on Form 10-Q filed on February 8, 2018 and May 3, 2018,
which are available at
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.


View Comments and Join the Discussion!